Boryung Pharmaceutical's new high blood pressure drug Tubero (a composite drug for dyslipidemia), which belongs to the company’s Kanarb family of hypertension drugs, made its debut in the Mexican market on Sept. 11 (Korea time).Tubero is Boryung’s fourth product to be introduced in Mexico, follo
The Ministry of Food and Drug Safety (MFDS) has decided to limit the number of pharmaceutical companies that can participate in a joint bioequivalence test for development of generic drugs in a bid to put the domestic generics market in order.Currently, small pharmaceutical companies can jointly car
As the government is planning to strengthen regulations on the development of generic drugs in the wake of last year's valsartan scandal, industry watchers are speculation whether this could trigger a restructuring of the pharmaceutical industry.If the government introduces new regulations on th